Sv Health Investors, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Sv Health Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.69 - $42.57 $25.3 Million - $73.2 Million	-1,719,576 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $2.06 Million - $3.46 Million	-111,972 Reduced 6.11%	1,719,576 $38.1 Million
Q1 2019 May 15, 2019	SELL	$16.51 - $31.1 $11.8 Million - $22.3 Million	-716,654 Reduced 28.12%	1,831,548 $52.4 Million
Q4 2018 Feb 14, 2019	SELL	$16.21 - $24.06 $507,178 - $752,789	-31,288 Reduced 1.21%	2,548,202 $50.3 Million
Q3 2017 Nov 14, 2017	BUY	$5.84 - $8.88 $15.1 Million - $22.9 Million	2,579,490	2,579,490 $17.4 Million

127

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $243M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Sv Health Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sv Health Investors, LLC with notifications on news.